Form 4 for IDXX Idexx Laboratories
Accepted 2025-05-23 00:00:00 ET · period of report 2025-05-21 · accession 0000874716-25-000094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-23 | 2025-05-21 | IDXX | SZOSTAK M ANNE | Dir | S - Sale+OE | $513.74 | -1,046 | 262 | -80% | -$537.4K |
| D | 2025-05-23 | 2025-05-21 | IDXX | SZOSTAK M ANNE | Dir | M - OptEx | $160.28 | +1,046 | 1,308 | +399% | +$167.7K |
| DI | 2025-05-23 | 2025-05-21 | IDXX | SZOSTAK M ANNE | Dir | S - Sale+OE | $512.34 | -1,260 | 1,801 | -41% | -$645.5K |
| D | 2025-05-23 | 2025-05-21 | IDXX | SZOSTAK M ANNE | Dir | M - OptEx | — | -1,046 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-21 | S | D | 1,046 | $513.74 | 262 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-21 | M | A | 1,046 | $160.28 | 1,308 | D Trust of M. Anne Szostak | — | — | (F2) The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares held by the Trust. |
| 3 | Common | Common Stock | 2025-05-21 | S | D | 1,260 | $512.34 | 1,801 | I | — | — | (F1) Represents the weighted average price of the shares sold ranging from a low of $511.81 to a high of $512.61 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 4 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2025-05-21 | M | D | 1,046 | — | 0 | D | $160.28 · — to 2027-05-02 | 1,046 Common Stock | (F4) Not applicable. (F3) Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of shareholders, whichever event was earlier. |